Abstract:Lung cancer is the leading cause of the incidence and mortality of malignant tumors in our country, seriously endangering people's lives and health. The treatment of lung cancer has made great progress in the past 10 years, and the 5-year survival rate of lung cancer in China has also increased from 16.1% to 19.7%, but about 75% of patients are still in advanced stages of lung cancer at the time of diagnosis, missing the best time for radical surgery. Early diagnosis can significantly improve the prognosis and survival of lung cancer patients. From the 5-year survival rate of lung cancer patients, it can be seen that the 5-year survival rate of stage Ⅰ patients was 77%-92%, while that of stage ⅢA-ⅣA patients was only 10%-36%, and there was a significant difference in the 5-year survival rate. Studies have shown that early-diagnosed and completely resected lung adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA) have 5-year disease-specific survival rates of 100% and 100%, respectively. Early diagnosis is the key to improving the prognosis of lung cancer. In order to further improve the level of early lung cancer diagnosis in China, especially the standardization in the diagnosis and evaluation of pulmonary nodules and early lung cancer, experts from the Lung Cancer Group of Chinese Thoracic Society formulated the "Chinese Expert Consensus on Diagnosis of Early Lung Cancer (2023 Edition)", on the basis of the actual situation in the field of diagnosis and treatment, with reference to the latest research data and relevant guidelines at home and abroad. Consensus on the application of artificial intelligence, big data and robotics, the Internet of Things and multidisciplinary cooperation in the diagnosis of early lung cancer, the management of pulmonary nodules and follow-up strategies for suspected early lung cancer, etc., were respectively recommended to provide references for clinicians in the diagnosis of early lung cancer, in order to further promote the early diagnosis of lung cancer in China.

Current Status and Challenges of Research on Lung Cancer Screening and Early Diagnosis

Biomarkers in Early Diagnosis and Screening of Lung Cancer

Advances in lung cancer screening and early detection

Early Detection of Lung Cancer: Low-Dose Computed Tomography Screening in China

[Minimally Invasive Therapies for Early Stage Non-small Cell Lung Cancer].

Early Screening and Management of Lung Cancer:A Weapon to Solve the Problem of Lung Cancer in China

Progress in the Early Diagnosis of Lung Cancer

Prevention and management of lung cancer in China.

The Methods and Clinical Significance of Early Diagnosis of Lung Cancer

Implementation Planning for Lung Cancer Screening in China.

The Present Situation of Early Screening of Lung Cancer in China

Lung Cancer Screening in China: Early-Stage Lung Cancer and Minimally Invasive Surgery 3.0

Research Progress and Application of Artificial Intelligence Technology in Lung Cancer Diagnosis

Developing technologies and areas of interest in lung cancer screening adjuncts

[Advances in Surgical Treatment of Early Stage Non-small Cell Lung Cancer].

China Lung Cancer Screening (CLUS) version 2.0 with new Techniques Implemented: Artificial Intelligence, Circulating Molecular Biomarkers and Autofluorescence Bronchoscopy

Research status and application prospect of artificial intelligence technology in lung tumors

Application analysis of ai technology combined with spiral CT scanning in early lung cancer screening

Chinese consensus on early diagnosis of primary lung cancer (2014 version)

[Chinese expert consensus on diagnosis of early lung cancer (2023 Edition)]

Lung Cancer Screening: Present Situation and Controversy